Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Dextenza 04mg Ophthalmic Insert

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05620901Early Phase 1Completed

DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

Showing all 1 trials

Research Network

Common Treatments

  • Dextenza 04mg Ophthalmic Insert1
  • Pred Forte1

Active Sponsors

  • Lejla Vajzovic, MD, FASRS1

Top Investigators

Related Conditions

  • Retinal Detachment Exudative1
  • Exudative Retinopathy1
  • Vitreoretinopathy1
  • Retinal Detachment Traction1
  • Retinal Hole1

Activity Timeline